Cancer
-
March 2, 2023
Eng invited to White House Cancer Moonshot forum
Vanderbilt's Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum. -
February 23, 2023
Trial seeks to expand therapies for biliary cancers
A Vanderbilt clinical trial seeks to optimize the effect of immunotherapies for patients with biliary tract cancers who have already progressed on first-line therapy. -
February 16, 2023
Breast cancer genetics: new insights
Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights. -
February 16, 2023
Patient undergoes novel therapy to treat pancreatic cancer
Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery. -
February 16, 2023
Tindle authors NCI guidance on treatment of cancer patients who smoke
Vanderbilt's Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute. -
February 9, 2023
‘Biopsy Queen’ reaches milestone number of procedures
Vanderbilt-Ingram Cancer Center's Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996. -
February 9, 2023
Vanderbilt-Ingram joins CancerLinQ quality initiative
Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.